Slingshot members are tracking this event:
AbbVie (ABBV) Submits NDA to U.S. FDA for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of All Major Genotypes of Chronic Hepatitis C
Slingshot Insights Explained
Dec 19, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Glecaprevir, Pibrentasvir, Chronic Hepatitis C